EMMAUS LIFE SCIENCES, INC.
CIK 0001420031
Revenue (TTM)
$15.08M
+2,836.4% YoY
Q1 May 2019
Net Income (TTM)
−$53.04M
−73.5% YoY
Q1 May 2019
EPS Diluted (TTM)
—
Q1 May 2019
Gross Margin
85.2%
Q1 May 2019
Operating Margin
-65.7%
Q1 May 2019
Net Margin
-351.8%
Q1 May 2019
Free Cash Flow (TTM)
−$5.37M
Q1 May 2019
Cash
$15.31M
Q1 May 2019
Total Debt
$10.34M
Q1 May 2019
Shares Outstanding
36.05M sh
Q1 May 2019